Literature DB >> 22733378

The different distribution patterns of FDG and FDG-labelled WBC in inflammatory and infectious lesions.

Sabire Yılmaz1, Meltem Ocak, Sertac Asa, Anar Aliyev, Meftune Ozhan, Metin Halac, Sait Sager, Levent Kabasakal, Kerim Sonmezoglu.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22733378     DOI： 10.1007/s00259-012-2170-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  4 in total

1.  Inflammation and infection: imaging properties of 18F-FDG-labeled white blood cells versus 18F-FDG.

Authors:  Daniela Pellegrino; Ali A Bonab; Stephen C Dragotakes; Justin T Pitman; Giuliano Mariani; Edward A Carter
Journal:  J Nucl Med       Date:  2005-09       Impact factor: 10.057

2.  The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography.

Authors:  S Osman; H J Danpure
Journal:  Int J Rad Appl Instrum B       Date:  1992-02

3.  Imaging infection with 18F-FDG-labeled leukocyte PET/CT: initial experience in 21 patients.

Authors:  Nicolas Dumarey; Dominique Egrise; Didier Blocklet; Bernard Stallenberg; Myriam Remmelink; Véronique del Marmol; Gaëtan Van Simaeys; Frédérique Jacobs; Serge Goldman
Journal:  J Nucl Med       Date:  2006-04       Impact factor: 10.057

4.  Noninvasive quantification of bowel inflammation through positron emission tomography imaging of 2-deoxy-2-[18F]fluoro-D-glucose-labeled white blood cells.

Authors:  Betty S Pio; Fergus R Byrne; Richard Aranda; Guylain Boulay; Karsten Spicher; Mark H Song; Lutz Birnbaumer; Michael E Phelps; Johannes Czernin; Daniel H S Silverman
Journal:  Mol Imaging Biol       Date:  2003 Jul-Aug       Impact factor: 3.488
  4 in total
  3 in total

1.  FDG and FDG-labelled leucocyte PET/CT in the imaging of prosthetic joint infection.

Authors:  Sabire Yılmaz Aksoy; Sertac Asa; Meftune Ozhan; Meltem Ocak; M Sait Sager; Melih Engin Erkan; Metin Halac; Levent Kabasakal; Kerim Sönmezoglu; Bedii Kanmaz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-06       Impact factor: 9.236

2.  Labelling and Clinical Performance of Human Leukocytes Labelled with 99mTc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent.

Authors:  S Auletta; D Riolo; M Varani; C Lauri; F Galli; A Signore
Journal:  Contrast Media Mol Imaging       Date:  2019-03-25       Impact factor: 3.161

Review 3.  Multiagent imaging of inflammation and infection with radionuclides.

Authors:  Christopher J Palestro; Andor W J M Glaudemans; Rudi A J O Dierckx
Journal:  Clin Transl Imaging       Date:  2013-11-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.